The Balance Control Mechanism of DPN Patients

Status Recruiting

Clinical Trial Summary

This study will evaluate the balance ability of DPN (diabetic peripheral neuropathy)patients, which will help us to understand the relationship between peripheral and central nervous system, in order to early diagnosis and prevent the fall in DPN patients.

Clinical Trial Description

DPN is one of the most common complications of diabetes. The clinical manifestation of DPN contains sensory reduction, pain, muscle wastage and so on. Sensory and motor nervous are one of the most important factors in balance control, the reduction of balance ability will result in high risk of fall.

Most studies about DPN are focus on peripheral nervous, however, the central nervous system may also be involved in DPN patients. In this study, force platform, proprioception test and fMRI will be used to evaluate balance ability, proprioception and the brain function information of DPN patients, which will help to understand the relationship between peripheral and central nervous system. ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02606747
Study type	Observational
Source	Peking University
Contact	Ye Wang, Ph. D
Phone	+8613718946837
Email	wangyesmile@gmail.com
Status	Recruiting
Phase	N/A
Start date	March 2015
Completion date	June 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04025320` - The Effect of Intraneural Facilitation Therapy on Diabetic Patients With Peripheral Neuropathy	N/A
Completed	`NCT02659007` - Less Neuropathy After Yoga- Managing Diabetic Neuropathy With Yoga	Phase 1
Completed	`NCT01953757` - A Nutritional Intervention for Diabetic Neuropathy (WCCR-DN2)	N/A
Completed	`NCT01707979` - NIR- and Multifrequent Impedance Spectroscopy on the Skin in Type 1 Diabetes	N/A
Completed	`NCT00608439` - Centella Asiatica Selected Triterpenes (CAST) for Diabetic Neuropathy	Phase 2
Completed	`NCT00576277` - Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AV411 in Neuropathic Pain	Phase 1/Phase 2
Completed	`NCT00235443` - A Follow-On Trial to Assess the Long Term Safety and Efficacy of SPM 927 in Painful Distal Diabetic Neuropathy	Phase 2/Phase 3
Completed	`NCT00830011` - Cognitive Behavioral Therapy for Painful Diabetic Neuropathy	N/A
Completed	`NCT00931879` - Lovaza® and Microvascular Function in Type 2 Diabetes	Phase 4
Completed	`NCT00101426` - Safety and Efficacy of AS-3201 in the Treatment of Diabetic Sensorimotor Polyneuropathy	Phase 3
Completed	`NCT00190970` - The Effect of Ruboxistaurin on Small Fiber Function	Phase 2
Completed	`NCT00238550` - Study of CBME in the Relief of Painful Diabetic Neuropathy	Phase 2
Completed	`NCT05573685` - Basket Study (CT-100-002) to Evaluate the Effects of a DiNaMo™ Component Training	N/A
Recruiting	`NCT02341261` - Activity for Diabetic Polyneuropathy	N/A
Completed	`NCT01822925` - Study of DA-9801 to Treat Diabetic Neuropathy	Phase 2
Completed	`NCT01690962` - A Nutritional Intervention for Diabetic Neuropathy	N/A
Terminated	`NCT00993018` - A Study of Effectiveness and Safety of JNJ-42160443 in Patients With Diabetic Painful Neuropathy	Phase 2
Withdrawn	`NCT02315235` - The Peripheral Mobilized Mononuclear Cell-based Therapy in Patient With Diabetic Neuropathy	N/A
Completed	`NCT00496457` - Efficacy Study With 500 mg QD of TRO19622 vs Placebo in Patients With Painful Peripheral Diabetic Neuropathy	Phase 2
Completed	`NCT02068027` - Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy	Phase 2